NCT03842254View on ClinicalTrials.gov

Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Autoimmune Hepatitis
Interventions
DRUG

Erythropoietin

Subcutaneous injection of erythropoietin 10,000 units

Trial Locations (2)

10029

Mount Sinai, New York

60611

Northwestern Medicine, Chicago

All Listed Sponsors
collaborator

Mount Sinai Hospital, New York

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Northwestern University

OTHER

NCT03842254 - Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease | Biotech Hunter | Biotech Hunter